Taiwan FDA registration 720b2528f34b14c11c10e47299d90308
Qizhe α fetoprotein in vitro reagent group
TW: 啟哲α胎蛋白體外試劑組
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd·Registered Dec 11, 2013 – Dec 07, 2016CancelledRegistration details
- Analysis ID
- 720b2528f34b14c11c10e47299d90308
Company information
- Manufacturer
- Longteng Biotechnology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Qizhe Biotechnology Co., Ltd
Product details
- Intended Use
- Qualitative detection of AFP in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Dec 11, 2013
- Expiry Date
- Dec 07, 2016
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Qizhe α fetoprotein in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 720b2528f34b14c11c10e47299d90308 and manufactured by Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices